JUNS
JUPITER NEUROSCIENCES, INC.
NASDAQ · Healthcare · Biotechnology · US
$2.35
−3.29%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$2.44
From 52W high−69.76%
Volume19477.00
Market cap$3.10M
P/E (TTM)—
P/S (TTM)47.9x
Div yield—
Key dataNov 4, 2026
Open
$2.44
From 52W high
−69.76%
Volume
19477.00
Market cap
$3.10M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
P/E (TTM)
—
RSI (14)
42.7
MomentumView details →
1D Return
−3.29%
YTD Return
+133.33%
SummaryUpdated Jun 1, 2026
Jupiter Neurosciences, Inc. (OTC:JUNS) is a clinical-stage biotechnology company founded in 2016 and headquartered in Jupiter, Florida. Originally established as Jupiter Orphan Therapeutics, Inc., the company rebranded to its current name in August 2021 to better reflect its focus on neurological conditions. Jupiter Neurosciences went public in January 2022 and specializes in developing treatments for rare neurological diseases and neurodegenerative conditions using a resveratrol-based platform technology.
Similar companies
Latest newsMore news →